Fred Alger Management’s Kyntra Bio KYNB Stock Holding History

Fred Alger Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-720	Closed	-$730K	–	486
2020 Q2	$730K	Hold	720	–	–	﹤0.01%	373
2020 Q1	$626K	Sell	720 -200	-22%	-$199K	﹤0.01%	346
2019 Q4	$986K	Hold	920	–	–	﹤0.01%	344
2019 Q3	$851K	Sell	920 -80	-8%	-$87.9K	﹤0.01%	342
2019 Q2	$1.13M	Buy	1,000 +80	+9%	+$87.6K	﹤0.01%	334
2019 Q1	$1.25M	Buy	920 +120	+15%	+$163K	0.01%	312
2018 Q4	$926K	Buy	+800	New	+$899K	﹤0.01%	327
2018 Q3	–	Sell	-200	Closed	-$313K	–	555
2018 Q2	$313K	Buy	+200	New	+$261K	﹤0.01%	376
2016 Q2	–	Sell	-1,000	Closed	-$532K	–	537
2016 Q1	$532K	Buy	1,000 +48	+5%	+$23.9K	﹤0.01%	416
2015 Q4	$725K	Buy	+952	New	+$632K	﹤0.01%	410

Other funds holding KYNB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fred Alger Management's KYNB Position: Q3 2020 in Review

Fred Alger Management sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 720 shares — an estimated $730K sold.

Fred Alger Management first reported a position in KYNB in Q4 2015 and held it in 10 quarters. The position peaked at $1.25M in Q1 2019. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

Fred Alger Management reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
Fred Alger Management sold 720 Kyntra Bio shares in Q3 2020, an estimated $730K.
Fred Alger Management first reported a position in Kyntra Bio in Q4 2015 and held it in 10 quarters.
Fred Alger Management's Kyntra Bio position peaked at $1.25M in Q1 2019.
208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Fred Alger Management's 13F filing for Q3 2020, filed 13 Nov 2020.